Avantor, Inc. ($AVTR) Stock Forecast: Down 5.2% Today

What is Avantor, Inc.?

Avantor, Inc. (AVTR) is a global provider of critical products and services to life sciences and advanced technology industries. The company is listed on the NYSE.

Why is Avantor, Inc. going down?

AVTR stock is down 5.2% on Jan 29, 2026 15:22

• The bearish movement in AVTR's stock price today can be attributed to several factors:
• Allegations of misrepresentation and increased competition leading to a federal securities lawsuit may have raised concerns among investors, impacting the stock negatively.
• Insider purchases by Sector Gamma AS and two directors, while initially positive, were overshadowed by Avantor missing its quarterly EPS estimates and providing lower-than-expected guidance for FY2025.
• The upcoming release of Q4 and full-year 2025 financial results, along with discussions on the outlook for 2026, has likely created uncertainty and caution among investors, contributing to the bearish sentiment.
• The ongoing investigations by multiple law firms into potential breaches of fiduciary duties by Avantor's officers and directors have added to the negative sentiment surrounding the stock, further pressuring its price downwards.

AVTR Price Chart

AVTR Technical Analysis

AVTR News

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Kuehn Law, PLLC is investigating Avantor, Inc. (NYSE: AVTR) for potential breaches of fiduciary duties by its officers and directors. A federal securities lawsuit alleges that Avantor misrepresented its competitive position and failed to disclose increased competition, making previous statements materially false. Investors who purchased AVTR shares before March 5, 2024, are encouraged to contact Kuehn Law.

https://www.morningstar.com/news/pr-newswire/20260128ny73381/kuehn-law-encourages-investors-of-avantor-inc-to-contact-law-firm

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Kuehn Law,PLLC is investigating whether officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders. The investigation stems from allegations that Avantor misrepresented its competitive position and faced negative effects from increased competition. The firm encourages investors who purchased AVTR prior to March 5, 2024, to contact them to discuss their rights.

https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-avantor-inc-to-contact-law-firm-302672958.html

Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (NYSE:AVTR) on behalf of investors who purchased securities prior to March 5, 2024, and continue to hold them. The investigation focuses on whether Avantor's officers and/or directors engaged in corporate wrongdoing. Shareholders are encouraged to contact the firm to assist with the inquiry.

https://www.accessnewswire.com/newsroom/en/business-and-professional-services/avantor-inc.-avtr-investigation-bronstein-gewirtz-and-grossman-l-1125981

Avantor, Inc. $AVTR Shares Acquired by Sector Gamma AS

Sector Gamma AS increased its stake in Avantor, Inc. (AVTR) by 28% in Q3, now holding 477,104 shares valued at $5.95 million. Additionally, two directors, Gregory L. Summe and Sanjeev K. Mehra, made significant insider purchases, bringing insider ownership to about 1.20%. Despite these acquisitions, Avantor missed its quarterly EPS estimates and provided lower-than-expected FY2025 guidance, leading to a consensus "Hold" rating and an average price target of $13.60.

https://www.marketbeat.com/instant-alerts/filing-avantor-inc-avtr-shares-acquired-by-sector-gamma-as-2026-01-25/

Avantor Sets Date for Q4, Full-Year Results as Investors Eye 2026 Outlook

Avantor, Inc. (AVTR) announced it will release its fourth-quarter and full-year 2025 financial results on February 11, 2026, before market open, followed by an 8:00 a.m. EST conference call. Investors are keen on the company's performance trends and its forward-looking statements for fiscal year 2026, which will be discussed on its investor relations website. Avantor is a global provider of critical products and services to life sciences and advanced technology industries.

https://www.mychesco.com/a/news/regional/avantor-sets-date-for-q4-full-year-results-as-investors-eye-2026-outlook/

Trending Today

Silver ($XAG) Commodity Forecast: Up 5.0% Today

Mantle ($MNT) Crypto Forecast: Down 5.1% Today

Binance Coin ($BNB) Crypto Forecast: Down 5.1% Today

XRP ($XRP) Crypto Forecast: Down 5.5% Today

Ethereum ($ETH) Crypto Forecast: Down 5.0% Today

Monero ($XMR) Crypto Forecast: Up 6.1% Today

Prime Medicine ($PRME) Stock Forecast: Down 5.1% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Down 5.2% Today

Unity Software ($U) Stock Forecast: Up 5.1% Today

Broadridge Financial Solutions Inc.Common Stock ($BR) Stock Forecast: Down 5.0% Today

Avantor, Inc. Price History

15.00.2026 - AVTR Stock was down 6.3%

• The decrease in Avantor's stock price might be linked to Pacific Capital Partners Ltd's substantial sell-off, resulting in a 22.5% reduction in its holdings.
• Despite recent insider purchases and significant institutional ownership, the decrease in Pacific Capital Partners Ltd's position could have influenced negative market sentiment.
• The anticipation surrounding the upcoming earnings announcement for the fourth quarter and full year of 2025 may be prompting investors to reassess their positions, contributing to the bearish trend.
• Falling slightly short of the quarterly EPS and revenue targets could also have played a role in adding downward pressure on the stock.

29.00.2026 - AVTR Stock was down 5.2%

• The bearish movement in AVTR's stock price today can be attributed to several factors:
• Allegations of misrepresentation and increased competition leading to a federal securities lawsuit may have raised concerns among investors, impacting the stock negatively.
• Insider purchases by Sector Gamma AS and two directors, while initially positive, were overshadowed by Avantor missing its quarterly EPS estimates and providing lower-than-expected guidance for FY2025.
• The upcoming release of Q4 and full-year 2025 financial results, along with discussions on the outlook for 2026, has likely created uncertainty and caution among investors, contributing to the bearish sentiment.
• The ongoing investigations by multiple law firms into potential breaches of fiduciary duties by Avantor's officers and directors have added to the negative sentiment surrounding the stock, further pressuring its price downwards.

10.11.2025 - AVTR Stock was up 5.5%

• The bullish movement in AVTR's stock today could be attributed to investors' optimism or confidence in the company's ability to navigate through the ongoing legal challenges and emerge successfully.
• Despite the pending class action lawsuits and allegations of securities fraud, investors might be focusing on the long-term growth prospects of the company and its resilience in the face of competitive pressures.
• The market movement could also indicate that investors believe AVTR will address the issues raised in the lawsuits effectively, leading to a positive outlook for the company's future performance.
• It is essential for investors to carefully monitor any developments related to the legal proceedings and assess their potential impact on AVTR's stock in the coming days.

05.00.2026 - AVTR Stock was up 2.2%

• The bullish movement in AVTR stock today can be attributed to increased confidence shown by institutional investors and insiders through significant share purchases.
• Avantor's participation in the 44th Annual J.P. Morgan Healthcare Conference might have sparked investor interest and optimism in the company's future prospects.
• Despite the stock trading near its 52-week low and recent earnings misses, substantial investments by funds like Kinney Asset Management and Olstein Capital Management suggest a belief in the company's potential turnaround.
• The combination of insider buying, institutional investments, and participation in key events are indicative of a positive sentiment shift towards Avantor, potentially driving the bullish movement in the stock today.

14.00.2026 - AVTR Stock was down 1.1%

• Today, Avantor (AVTR) experienced a strong bearish movement in the stock market, likely influenced by the following factors:
• The announcement of the upcoming release of Avantor's fourth quarter and full-year 2025 financial results may have created uncertainty among investors, leading to a sell-off of shares in anticipation of the report.
• The partnership with p-Chip Corporation, Choice One Rx, and RxERP to launch a trial demonstrating digital traceability of drug supply chains could have raised concerns about potential costs or challenges associated with implementing new technologies.
• Despite Avantor's CEO presenting at the J.P. Morgan Healthcare Conference and highlighting the company's strategic positioning in the life sciences industry, investors may have focused more on short-term financial performance, contributing to the bearish market movement.

06.00.2026 - AVTR Stock was up 6.5%

• Institutional investors like VIRGINIA RETIREMENT SYSTEMS ET Al and company directors Gregory L. Summe and Sanjeev K. Mehra have been actively purchasing AVTR stock, showcasing confidence in its future.
• Avantor's participation in the 44th Annual J.P. Morgan Healthcare Conference is likely boosting investor confidence, offering a platform for the company to exhibit its products.
• Despite recent challenges like a significant stock price decline and a Q3 earnings miss, increased investment from Kinney Asset Management and their support for Avantor's potential turnaround through a new share repurchase program could be driving optimism among investors, leading to the current bullish trend.

29.09.2025 - AVTR Stock was down 15.0%

• AVTR stock declined today after the publication of its Q3 financial results.
• Both earnings and revenue numbers were below projections, reflecting a possibly subdued performance in the latest quarter.
• The disappointing financial results likely eroded investor confidence, leading to the bearish trajectory in the stock price.
• Investors may adopt a cautious stance toward AVTR's future outlook until the company exhibits improved financial results and aligns with market expectations.

21.10.2025 - AVTR Stock was up 5.2%

• The bullish movement in AVTR's stock price today could be attributed to the following factors:
• Despite facing pending class action lawsuits, investors may have gained confidence in the company's ability to navigate through legal challenges.
• The upcoming deadline for shareholders to file motions in the class action lawsuits might have led to increased trading activity and speculation in the stock.
• Investors might be optimistic about AVTR's future prospects or potential resolutions to the legal issues, driving the stock price higher.
• Market sentiment surrounding AVTR could have been positively influenced by external factors such as industry trends or broader market conditions, contributing to the bullish movement.

28.00.2026 - AVTR Stock was down 5.2%

• Sector Gamma AS increased its stake in Avantor, Inc., and two directors made insider purchases, but the company missed its quarterly EPS estimates and provided lower-than-expected guidance, leading to a consensus "Hold" rating and a decrease in stock value.
• Investors are eagerly awaiting Avantor's Q4 and full-year 2025 financial results, as well as insights into the company's 2026 financial outlook. Uncertainty surrounding these upcoming announcements may have contributed to the bearish market movement.
• Avantor has been recognized as a significant player in lab infrastructure, supplying essential materials for various industries, which presents a positive long-term investment outlook. However, the discrepancy between market expectations and the company's recent performance could have influenced today's bearish trend.

29.09.2025 - AVTR Stock was down 17.3%

• AVTR stock faced bearish movement post earnings and revenue announcement, reflecting weaker demand trends.
• The company's challenges with subdued demand were highlighted by the earnings and revenue miss during the quarter.
• Despite the underwhelming performance, Avantor displayed confidence in its future by announcing a buyback program to reinforce its long-term value proposition.
• The unanticipated earnings and revenue disappointments likely triggered a reassessment among investors, contributing to the downward pressure on the stock in the market.

22.07.2025 - AVTR Stock was up 5.3%

• An investment firm has taken a stake in Avantor, believing that the company's underperformance is due to internal issues within the leadership team.
• This development has likely sparked investor optimism as the involvement of an activist investor suggests potential strategic changes and improvements within the company.
• The market movement could be a reflection of investor confidence in the investment firm's ability to unlock value in Avantor through strategic initiatives and operational enhancements.

31.09.2025 - AVTR Stock was up 5.4%

• Today's positive movement in AVTR's stock price can be linked to the following factors:
• Despite facing several class action lawsuits, investor confidence in Avantor's ability to address these legal challenges remains steady.
• The market's favorable response to any potential resolutions or actions taken by Avantor regarding the lawsuits demonstrates resilience in the midst of legal scrutiny.
• Investors appear to be emphasizing the company's core business performance and growth prospects over the current legal issues, prompting an upward trend in the stock price.
• The rise in bullish sentiment may also suggest that market participants believe the long-term impact of the lawsuits on Avantor's performance could be minimal, resulting in heightened interest in purchasing the stock.